Provided by Tiger Fintech (Singapore) Pte. Ltd.

Unicycive Therapeutics, Inc.

5.85
+0.18003.17%
Volume:285.65K
Turnover:1.66M
Market Cap:125.72M
PE:-2.02
High:6.00
Open:5.68
Low:5.67
Close:5.67
52wk High:11.00
52wk Low:3.71
Shares:21.49M
Float Shares:13.01M
Volume Ratio:1.22
T/O Rate:2.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8962
EPS(LYR):-5.6466
ROE:-102.29%
ROA:-44.22%
PB:3.35
PE(LYR):-1.04

Loading ...

Unicycive Therapeutics: Buy Rating Backed by Promising OLC Progress and Strategic Market Positioning

TIPRANKS
·
Nov 16

Unicycive Therapeutics Doubles Stock Sale Agreement

TIPRANKS
·
Nov 15

BRIEF-Unicycive Therapeutics Increases ATM Offering To $100 Million - SEC Filing

Reuters
·
Nov 15

Unicycive Therapeutics Inc - Increases Atm Offering to $100 Mln - SEC Filing

THOMSON REUTERS
·
Nov 15

Unicycive Therapeutics Q3 EPS $(0.46) Beats $(0.51) Estimate, Cash And Cash Equivalents Totaled $42.7M, With Cash Runway Into 2027

Benzinga
·
Nov 12

Unicycive Therapeutics Showcases Kidney Disease Drug Pipeline and OLC Launch Strategy

Reuters
·
Nov 12

Unicycive Therapeutics reports Q3 results with $42.7 million cash and plans OLC NDA resubmission by year-end

Reuters
·
Nov 12

Unicycive Therapeutics Inc - on Track to Resubmit Nda for Oxylanthanum Carbonate by Year-End

THOMSON REUTERS
·
Nov 12

Unicycive Therapeutics Reports Oxylanthanum Carbonate Cuts Pill Burden in Hyperphosphatemia Trial

Reuters
·
Oct 30

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), United Therapeutics (UTHR) and Unicycive Therapeutics (UNCY)

TIPRANKS
·
Oct 30

Unicycive Therapeutics Showcases Kidney Disease Drug Pipeline and OLC Development Plans

Reuters
·
Oct 30

Guggenheim Sticks to Its Buy Rating for Unicycive Therapeutics (UNCY)

TIPRANKS
·
Oct 30

Unicycive Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Oct 29

Unicycive Therapeutics Inc : H.c. Wainwright Raises Target Price to $22 From $9

THOMSON REUTERS
·
Oct 29

Unicycive Therapeutics to Resubmit OLC NDA After FDA Meeting

Reuters
·
Oct 28

Unicycive Therapeutics Provides Update From FDA Type a Meeting and Expects to Resubmit Olc Nda Before Year-End

THOMSON REUTERS
·
Oct 28

Class Action Lawsuit Filed Against Unicycive Therapeutics Inc for Alleged Securities Fraud

Reuters
·
Oct 10

Unicycive Therapeutics Faces Class Action Lawsuit Alleging Securities Fraud; Investors Urged to Take Action

Reuters
·
Oct 04

Unicycive Therapeutics Inc. Shares Corporate Presentation Highlighting Progress in Kidney Disease Treatments and OLC Launch Readiness

Reuters
·
Oct 02

UNCY Lawsuit Alert! Class Action Lawsuit Against Unicycive Therapeutics

TIPRANKS
·
Sep 30